Close Menu

Breaking News

Zef Scientific will distribute PathogenDx's molecular pathogen detection platform for cannabis, hemp, agriculture, and food safety applications.

The researchers found that background TP53 gene mutations increase with age and could affect efforts to develop liquid biopsy-based cancer screening tests.

The group will integrate IDT's oligo synthesis technology with 3CR's PCR Allele Competitive Extension (PACE) Genotyping Master Mix and expertise in developing assays.

The funding will be used to support clinical validation and expand market access for the firm's endometriosis diagnostic test.

Geisinger and UPenn researchers found that Titin truncations revealed by exome sequencing increased DCM risk in those with European but not with African ancestry.

The firm said its assay is a real-time qPCR test for the direct detection of methicillin-resistant Staphylococcus aureus DNA in nasal swabs.

The FDA approved FoundationOne CDx as a companion diagnostic for olaparib for first-line maintenance therapy in BRCA-mutated advanced ovarian cancer.

Overall, the index climbed almost 11 percent in June over the previous month, beating the Dow Jones Industrial, the Nasdaq, and the Nasdaq Biotech Index.

Under the non-exclusive agreement, Germany's Merck will globally distribute RevoluGen's Fire Monkey/Fire Flower kit for the extraction of high molecular weight DNA.

The firm's CEO said it is continuing to develop its distributor network to make its tests available in centralized and decentralized settings globally.

Last week, GenomeWeb readers were most interested in the USPTO's new patent interference involving CRISPR patents held by the Broad Institute and UC Berkeley.

As expected, the UK's Competition and Markets Authority is referring the proposed Illumina acquisition of PacBio for an in-depth Phase 2 investigation.

iCubate said that it now has a comprehensive solution within European markets for the detection of bloodstream bacteria and important resistance markers.

The suits, targeting products that include the BGISEQ-500 and MGISEQ-2000 platforms, add fuel to the ongoing patent dispute between the two firms.

Researchers analyzed RNA sequencing data gathered from induced pluripotent stem cells as they differentiated into heart muscle cells.

The agreement consists of a $100 million revolving credit facility, a $100 million initial term loan, and a $50 million delayed-draw term loan.

The partnership will make public and custom transcriptomic datasets available directly through Genestack's recently introduced Omics Data Manager system.

The company develops assays and reagents for tissue-based biomarker research and discovery including its UltiMapper line of multiplexed assays.

By analyzing thousands of cancer genomes, investigators identified hotspots for passenger mutations  at DNA hairpin sites that are a preferred substrate for APOBEC, a cytidine deaminase.

Regulators in the country granted additional approval of the test as a companion diagnostic for Rozlytrek, marketed in Japan by Roche's Chugai Pharmaceutical.

Researchers tracked down monogenic risk variants, carriers, disease culprits, and more for 50 individuals with cardiomyopathy and 50 unaffected participants.

The closure has no impact on the firm's other Los Gatos location, the original home of GeneWeave Biosciences, which Roche acquired in 2015 for up to $425 million.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.